IQVIA Holdings Inc. ($IQV) Stock Forecast: Up 5.5% Today

What is IQVIA Holdings Inc.?

IQVIA Holdings Inc. (IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the healthcare industry. The company has been experiencing a bullish market movement today.

Why is IQVIA Holdings Inc. going up?

IQV stock is up 5.5% on Jan 6, 2026 15:01

• Some investors, including Community Trust & Investment Co., have reduced their stakes in IQVIA Holdings Inc., while others like Asset Dedication LLC and J.Safra Asset Management Corp. have increased their holdings, showing mixed sentiments among investors.
• IQVIA stock reached a 52-week high due to strong market performance, recent strategic decisions such as refinancing loans and a collaboration with Amazon Web Services, and positive adjustments in analyst price targets, reflecting investor confidence and growth prospects.
• The temporary suspension of the new 340B Drug Pricing Program rebate model may have had a positive impact on IQVIA by easing financial pressures on hospitals and potentially increasing demand for IQVIA's services in the life sciences sector.
• Despite competition from companies like Charles River Laboratories and ICON plc, IQVIA's strategic positioning and recent positive developments are likely contributing to its bullish market movement today.

IQV Price Chart

IQV Technical Analysis

IQV News

Community Trust & Investment Co. Cuts Stock Position in IQVIA Holdings Inc. $IQV

Community Trust & Investment Co. reduced its stake in IQVIA Holdings Inc. (NYSE:IQV) by 4.0% in the third quarter, now owning 108,911 shares valued at $20,687,000. Other institutions like Asset Dedication LLC and J.Safra Asset Management Corp. increased their holdings in IQVIA. Analysts have given the stock a consensus "Moderate Buy" rating with a target price of $243.19, following upgrades from firms like Jefferies Financial Group and Evercore ISI.

https://www.marketbeat.com/instant-alerts/filing-community-trust-investment-co-cuts-stock-position-in-iqvia-holdings-inc-iqv-2026-01-06/

Iqvia stock hits 52-week high at 234.33 USD By Investing.com

IQVIA Holdings Inc. (IQV) stock has reached a new 52-week high of $234.33, driven by strong market performance, with a 14.17% return over the past year and a 37.22% surge in six months. The company, which has a market cap of $39.87 billion and a "GOOD" financial health rating, is seen as slightly undervalued according to InvestingPro's Fair Value analysis. Recent strategic moves, such as refinancing existing loans and a collaboration with Amazon Web Services, along with positive analyst price target revisions, suggest continued investor confidence and growth prospects for the life sciences tools and services provider.

https://ca.investing.com/news/company-news/iqvia-stock-hits-52week-high-at-23433-usd-93CH-4386206

Hospitals aren't ringing in a new 340B rebate program

A federal court has temporarily halted the implementation of a new 340B Drug Pricing Program rebate model, a ruling celebrated by hospitals. Hospitals claimed the proposed model, which would require them to purchase drugs at full price and then seek rebates, would cost them over $400 million and create significant administrative burdens. Despite an analysis suggesting minimal financial impact on hospitals, court officials agreed with hospital groups that the rule demonstrated an "anemic" administrative record.

https://www.techtarget.com/revcyclemanagement/news/366636804/Hospitals-arent-ringing-in-a-new-340B-rebate-program

Charles River Laboratories: The Quiet Infrastructure Powering the Next Wave of Drug Discovery

Charles River Laboratories has evolved into a comprehensive, end-to-end preclinical R&D and manufacturing platform, serving as the "invisible backbone" for modern drug discovery. The company offers integrated services from target discovery to safety assessment and advanced biologics manufacturing, positioning itself as a critical infrastructure provider for biotechs and pharmas. Its strategic advantages include an end-to-end ecosystem, deep regulatory expertise, early adoption in advanced therapies, and trusted partner status, making it a leveraged play on the health and innovation of the biotech sector.

https://www.ad-hoc-news.de/boerse/ueberblick/charles-river-laboratories-the-quiet-infrastructure-powering-the-next/68459099

ICON plc Is Quietly Eating Wall Street: Is ICLR the Undervalued Game-Changer No One On TikTok Knows

ICON plc (ICLR) is a largely unrecognized clinical research organization that plays a crucial role in drug development, making it a potentially undervalued stock. Despite its high market cap and impact, it lacks social media attention, appealing to "smart money" investors. The article suggests it is a reliable long-term investment due to its essential and recurring business model, scale, data leverage, and quality leadership in the CRO space, contrasting it with flashier, social-media-driven stocks.

https://www.ad-hoc-news.de/boerse/ueberblick/icon-plc-is-quietly-eating-wall-street-is-iclr-the-undervalued/68458539

Trending Today

Vaulta (prev.EOS) ($A) Crypto Forecast: Down 5.1% Today

ZCash ($ZEC) Crypto Forecast: Down 6.8% Today

XRP ($XRP) Crypto Forecast: Down 5.3% Today

JasmyCoin ($JASMY) Crypto Forecast: Up 21.2% Today

Silver ($XAG) Commodity Forecast: Up 6.3% Today

Exelon Corporation ($EXC) Stock Forecast: Up 0.9% Today

Norwegian Cruise Line Holdings Ltd. ($NCLH) Stock Forecast: Up 5.3% Today

Booking Holdings Inc. ($BKNG) Stock Forecast: Down 0.3% Today

Chemours Company (The) ($CC) Stock Forecast: Up 5.3% Today

Digital Ocean Holdings ($DOCN) Stock Forecast: Up 6.2% Today

IQVIA Holdings Inc. Price History

28.09.2025 - IQV Stock was up 0.8%

• IQVIA Holdings (IQV) reported better-than-expected earnings and revenue for the third quarter, indicating strong financial performance.
• The company's focus on biopharma strength and cost control has likely contributed to the positive results, showcasing its ability to adapt to industry dynamics.
• Investors may be optimistic about IQV's future prospects, considering its ability to outperform expectations in a challenging market environment.
• The bullish movement in IQV's stock price could be a reflection of confidence in the company's strategic direction and growth potential.

24.06.2025 - IQV Stock was up 7.6%

• IQV stock had a strong bullish movement today.
• The positive earnings report for the second quarter, with earnings and revenue beating estimates and showing year-over-year growth, likely fueled the bullish trend.
• Despite the strong performance, the cut in 2025 EBITDA guidance may have tempered some of the initial excitement in the market.
• The overall market uncertainty could have been overshadowed by IQV's impressive financial results, leading to the bullish movement in the stock.

05.00.2026 - IQV Stock was up 1.0%

• The increased stake by North Growth Management Ltd. and positive Q3 earnings results exceeding expectations likely contributed to the bullish movement.
• Despite the reduction in holdings by JARISLOWSKY FRASER Ltd and Generali Asset Management SPA SGR, the overall sentiment from analysts and brokers with raised price targets and ratings supported the stock's upward trajectory.
• The contrast between IQVIA's steady growth and undervalued perception of ICON plc in the clinical research space may have also attracted investors looking for reliable long-term investments.
• Overall, the combination of positive institutional investments, strong financial performance, and optimistic future guidance propelled IQV's bullish movement in the market today.

07.04.2025 - IQV Stock was up 5.5%

• Impressive Q1 earnings and revenues exceeded analysts' projections, particularly in the Research and Development, and Technology and Analytics sectors.
• CEO's mention of the company's adept handling of uncertain market conditions boosted investor confidence and generated positive market sentiment towards IQVIA.
• The increased sales outlook for 2025 and upheld EPS guidance added to the positive momentum, indicating a promising growth path for the company in the upcoming quarters.
• IQVIA's strong financial performance and strategic positioning in significant segments drove the stock to a bullish trajectory, demonstrating investors' confidence in the company's future outlook.

06.00.2026 - IQV Stock was up 5.5%

• Some investors, including Community Trust & Investment Co., have reduced their stakes in IQVIA Holdings Inc., while others like Asset Dedication LLC and J.Safra Asset Management Corp. have increased their holdings, showing mixed sentiments among investors.
• IQVIA stock reached a 52-week high due to strong market performance, recent strategic decisions such as refinancing loans and a collaboration with Amazon Web Services, and positive adjustments in analyst price targets, reflecting investor confidence and growth prospects.
• The temporary suspension of the new 340B Drug Pricing Program rebate model may have had a positive impact on IQVIA by easing financial pressures on hospitals and potentially increasing demand for IQVIA's services in the life sciences sector.
• Despite competition from companies like Charles River Laboratories and ICON plc, IQVIA's strategic positioning and recent positive developments are likely contributing to its bullish market movement today.

08.06.2025 - IQV Stock was up 2.2%

• A 29.88% increase in IQV's short percent of float could indicate a growing bearish sentiment among investors.
• Despite the rise in short interest, the stock experienced a bullish movement, suggesting potential positive developments driving investor optimism.
• Investor positivity may be linked to recent company announcements, strategic partnerships, or earnings reports, resulting in the upward movement of IQV's stock price.
• Monitoring short interest data and market trends is crucial for traders to make informed decisions about IQV's future performance.

06.04.2025 - IQV Stock was down 4.4%

• The bearish movement in IQV's stock today could be due to investors' concerns about the upcoming Q1 earnings.
• Despite anticipated growth in the R&DS and TAS segments, investors may be cautious about the company's overall performance for the quarter.
• Insights from analysts on key performance measures might have raised doubts or uncertainty among investors, leading to the bearish market movement.
• Market participants may be waiting for the earnings release to gain a clearer picture of IQVIA's financial health and future outlook, causing the stock to decline in the short term.

10.03.2025 - IQV Stock was down 5.9%

• Despite a recent surge in share price, IQVIA (IQV) experienced a strong bearish movement today.
• The bullish movement in the last session may have been short-lived, as the latest trend in earnings estimate revisions does not support further price increase in the near term.
• The market may have reacted negatively to this disconnect between the recent price surge and the lack of support from earnings estimates, leading to the bearish movement in IQV's stock today.

22.06.2025 - IQV Stock was up 15.7%

• IQV is experiencing a strong bullish movement today, likely driven by positive market sentiment and anticipation surrounding its upcoming Q2 earnings.
• Analysts are optimistic about IQV's performance for the quarter, with expectations of both earnings and revenues to rise on the back of strong demand across its segments.
• Investors may be reacting positively to the potential growth in earnings, despite some concerns raised about the company not meeting all the key expectations for a likely earnings beat.
• Overall, the bullish movement in IQV's stock today could be attributed to the market's optimism and anticipation of a positive earnings, outweighing any potential concerns about meeting all expectations.

11.02.2025 - IQV Stock was down 5.1%

• Despite having a diversified client base and unique data offerings, IQVIA's stock experienced a bearish movement today.
• The low liquidity concerns may have contributed to the downward trend in the stock price.
• Investors might be cautious due to potential challenges related to liquidity, which could be impacting the market sentiment and driving the bearish movement in IQV's stock today.

22.06.2025 - IQV Stock was up 17.5%

• IQVIA (IQV) experienced a strong bullish movement today following its Q2 earnings report.
• The company surpassed earnings and revenue estimates for the quarter, showcasing a 6.4% increase in earnings and a 5.5% rise in revenue year-over-year.
• Despite cutting its 2025 EBITDA guidance, investors were optimistic about IQVIA's performance, driven by strong demand across its segments.
• The positive earnings report and optimistic outlook for the stock propelled IQV's bullish movement as investors showed confidence in the company's ability to deliver results in a competitive market.

04.11.2025 - IQV Stock was down 5.2%

• Today, the market witnessed a bearish movement despite IQV's recent stock price increase and optimistic Q3 financial results.
• The decline could be attributed to some investors seizing the opportunity to take profits after the stock's substantial growth in recent months.
• Analysts' positive outlook on IQVIA Holdings, evident through the "Strong Buy" consensus rating and raised price targets, implies that the current bearish trend may be a temporary correction rather than a prolonged shift.
• Amidst uncertainties in the broader market, investors appear to be reassessing their positions in IQVIA Holdings, resulting in a bearish movement despite favorable company-specific developments.